Correlation Between Neuropace and Align Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Align Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Align Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Align Technology, you can compare the effects of market volatilities on Neuropace and Align Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Align Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Align Technology.

Diversification Opportunities for Neuropace and Align Technology

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between Neuropace and Align is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Align Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Align Technology and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Align Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Align Technology has no effect on the direction of Neuropace i.e., Neuropace and Align Technology go up and down completely randomly.

Pair Corralation between Neuropace and Align Technology

Given the investment horizon of 90 days Neuropace is expected to under-perform the Align Technology. But the stock apears to be less risky and, when comparing its historical volatility, Neuropace is 1.85 times less risky than Align Technology. The stock trades about -0.21 of its potential returns per unit of risk. The Align Technology is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  17,916  in Align Technology on June 3, 2025 and sell it today you would lose (3,720) from holding Align Technology or give up 20.76% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Align Technology

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Neuropace has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in October 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Align Technology 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Align Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in October 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Neuropace and Align Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Align Technology

The main advantage of trading using opposite Neuropace and Align Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Align Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Align Technology will offset losses from the drop in Align Technology's long position.
The idea behind Neuropace and Align Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities